Research
The order that can stop a tissue establishment
For human tissue products, the agency does not have to ask a firm to recall. It can order retention, recall, destruction, or a halt to manufacturing, and in a danger case the order is effective immediately.
A different instrument from the one people picture
A drug recall is normally something a company does. The agency asks, negotiates, classifies the hazard afterward, and monitors.
The tissue rules contain a different instrument. It is an order, issued by the agency, and the firm on the receiving end is told what will happen rather than asked.
The section is titled orders of retention, recall, destruction, and cessation of manufacturing. Those are four separate powers in one section.
Understanding this changes how a reader should interpret enforcement news about a tissue-derived product. The absence of a company announcement does not mean nothing has been ordered.
What has to be found before an order can issue
The threshold is a finding of reasonable grounds to believe, not proof. Three alternative grounds are listed and any one will do.
That the product is violative because it was manufactured in violation of these regulations, so the conditions of manufacture do not provide adequate protections against risks of communicable disease transmission.
That the product is infected or contaminated so as to be a source of dangerous infection to humans.
Or that an establishment is in violation of these regulations and therefore does not provide adequate protections against the risks of disease transmission.
The first and third grounds are about how something was made. Neither requires anything to have been found in a product.
The four things the agency can do
Once a ground is found, the agency may take one or more of three listed actions, and the first of those bundles two orders together.
It may serve the distributor a written order that the product be recalled and destroyed, as appropriate. It may also serve people in possession an order to retain it until it is recalled, destroyed, disposed of as agreed, or its safety is confirmed.
It may take possession of the violative product, or destroy it.
Or it may serve the establishment an order to cease manufacturing until compliance with the regulations of this part has been achieved.
When a cessation order takes effect
The cessation order is the one with a timing rule, and the rule turns on danger.
Where the agency determines there are reasonable grounds to believe there is a danger to health, the order is effective immediately.
In other situations it takes effect after the later of two events: the passage of five working days from the establishment's receipt of the order, or a decision in a hearing if one is requested.
So a firm gets a short window in the ordinary case and none at all in the urgent one. The distinction between those two paths is a determination the agency makes.
The order has to say why
A written order issued under this section will state with particularity the facts that justify it. That is a substantive requirement, not a formality.
A cessation order carries an additional duty of specificity. It will specify the regulations with which compliance must be achieved, and will ordinarily specify the particular operations covered.
After receipt of a cessation order that is in effect, the firm must not resume operations without prior written authorization from the agency.
That is the sentence that gives the order its weight. Stopping is ordered, and restarting requires permission in writing.
Five working days, and the alternative to destruction
A recall or destruction order will ordinarily provide that the action happen within five working days from the date the order is received.
In the meantime, the establishment in possession must not distribute or dispose of the product in any manner except to recall or destroy it consistent with the order, under agency supervision.
There is an alternative path. Other arrangements for assuring proper disposition may be agreed between the recipient of the order and the agency.
The regulation gives an example of what such an arrangement can look like. Providing records or other written information that adequately ensure the product was recovered, processed, stored and distributed in conformance with this part. And that the donor was determined eligible. In other words, a firm may be able to answer an order with documentation.
The hearing right, and the clock on it
The recipient of an order may request a hearing under the agency's general hearing procedures. The window is short.
The request must be made within five working days of receiving a written order for retention, recall, destruction or cessation, or within five working days of the agency taking possession of a product.
Requesting a hearing does two different things depending on the order. An order of destruction will be held in abeyance pending resolution of the hearing request.
A cessation order is not automatically stayed. Where it is not stayed by the Commissioner of Food and Drugs, the regulation provides for an expedited hearing on request.
One category is carved out entirely: the agency will not issue an order for the destruction of reproductive tissue under this section, nor carry out such destruction itself.
The inspection power that precedes all of it
Orders do not appear from nowhere. The same subpart contains the inspection authority that produces the findings.
An establishment that manufactures these products, whether or not under contract, must permit inspection of any manufacturing location at any reasonable time and in a reasonable manner.
The scope of what can be looked at is listed at length. It names the establishment, facilities, equipment, finished and unfinished materials, containers, processes and products. It goes on to procedures, labeling, records, files, papers, and the controls required to be maintained under the part.
Two details make this sharper than a scheduled audit. The inspection "may be made with or without prior notification and will ordinarily be made during regular business hours." And the frequency of inspection "will be at the agency's discretion."
Investigators may take samples, review and copy any records required to be kept under the part, and use other appropriate means to record evidence of observations.
And the border, which is a separate checkpoint
Imported tissue products get their own section. The importer of record must notify the relevant agency district, either before or at the time of importation.
The notification has to carry sufficient information, including information submitted through the customs electronic data interchange system, for the agency to make an admissibility decision.
Until that decision is made, the product must be held intact by the importer or consignee, under conditions necessary to prevent transmission of communicable disease. It may be transported under quarantine to the consignee while the documentation is reviewed.
Two carve-outs exist, for certain reproductive products donated by a sexually intimate partner and, with a stated exception, for peripheral blood stem and progenitor cells.
What this is worth knowing
The enforcement picture for tissue products is not the recall picture for drugs. An order can compel retention, recall, destruction or a manufacturing halt, on a finding of reasonable grounds rather than a proven defect.
Two of the three grounds are about manufacturing conditions. A firm can be ordered to stop without anyone finding a contaminated unit.
The response window is five working days for both the action and the hearing request, which is faster than most people assume enforcement moves.
None of this is a public feed. Orders are served on firms, and this article does not state how often they issue or to whom, because that is a separate question from what the instrument is.
Key takeaways
- The agency can order retention, recall, destruction, or a halt to manufacturing for a tissue product.
- The trigger is reasonable grounds to believe one of three conditions exists, not proof of a defect.
- Two of the three grounds concern manufacturing conditions rather than the contents of a container.
- A cessation order is effective immediately where the agency finds a danger to health.
- Recall or destruction is ordinarily required within five working days, and a hearing must be requested in the same window.
- Inspections may occur without prior notification, at a frequency left to agency discretion.
Frequently asked questions
Can the agency force a recall of a tissue product?
Yes. The trigger is a finding of reasonable grounds to believe one of three stated conditions exists. The agency may then serve the distributor a written order that the product be recalled and destroyed as appropriate, and order people in possession to retain it. It may also take possession of or destroy the product, or order the establishment to cease manufacturing.
How quickly does a cessation order take effect?
Immediately, where the agency determines there are reasonable grounds to believe there is a danger to health. Otherwise it takes effect after the later of five working days from the establishment's receipt of the order, or a decision in a hearing if the establishment requests one.
Can a firm contest one of these orders?
It can request a hearing under the agency's general hearing procedures, within five working days of receiving the order or of the agency taking possession of a product. An order of destruction is held in abeyance pending resolution of the request. A cessation order is not automatically stayed, though an expedited hearing is provided for where it is not stayed by the Commissioner.
Does a tissue establishment get notice before an inspection?
Not necessarily. The regulation states an inspection may be made with or without prior notification and will ordinarily be made during regular business hours, and that the frequency of inspection is at the agency's discretion. Investigators may take samples and review and copy any records required to be kept under the part.
What happens to an imported tissue product at the border?
The importer of record must notify the relevant agency district before or at the time of importation, with enough information for an admissibility decision. The product must be held intact under conditions necessary to prevent disease transmission until that decision is made, though it may be moved under quarantine to the consignee while the paperwork is reviewed.
Sources
Each document below is named as it names itself, with the date printed on that document rather than the day it was read.
- 21 CFR 1271.390, Applicability — Electronic Code of Federal Regulations, title 21, August 2026
- 21 CFR 1271.400, Inspections — Electronic Code of Federal Regulations, title 21, August 2026
- 21 CFR 1271.420, HCT/Ps offered for import — Electronic Code of Federal Regulations, title 21, November 2016
- 21 CFR 1271.440, Orders of retention, recall, destruction, and cessation of manufacturing — Electronic Code of Federal Regulations, title 21, August 2026